Page last updated: 2024-08-23

tetradecanoylphorbol acetate and Pulmonary Eosinophilia

tetradecanoylphorbol acetate has been researched along with Pulmonary Eosinophilia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Balakrishnan, A; Ezhilarasan, R; Krishnamoorthy, B; Miyamoto, S; Narayanan, K1
Barnes, PJ; Chanez, P; Chung, KF; Dent, G; Yukawa, T1

Other Studies

2 other study(ies) available for tetradecanoylphorbol acetate and Pulmonary Eosinophilia

ArticleYear
Targeting apoptotic signalling pathway and pro-inflammatory cytokine expression as therapeutic intervention in TPE induced lung damage.
    Cell biology international, 2003, Volume: 27, Issue:4

    Topics: Cell Line; Cytokines; Dose-Response Relationship, Drug; Drug Delivery Systems; Gene Expression Regulation; Glycoproteins; Humans; Hydrocortisone; Inflammation; Lung; Pulmonary Eosinophilia; Signal Transduction; Tetradecanoylphorbol Acetate

2003
Generation of oxygen free radicals from blood eosinophils from asthma patients after stimulation with PAF or phorbol ester.
    The European respiratory journal, 1990, Volume: 3, Issue:9

    Topics: Adult; Aged; Asthma; Eosinophils; Female; Free Radicals; Humans; Luminescent Measurements; Male; Middle Aged; Oxygen; Oxygen Consumption; Platelet Activating Factor; Pulmonary Eosinophilia; Rhinitis; Tetradecanoylphorbol Acetate

1990